Celastrol Ameliorates Hypoxia‐Induced Pulmonary Hypertension by Regulation of the PDE5‐cGMP‐PKG Signaling Pathway

Fuente: Wiley Open Access
Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Junlan Tan, Xianya Cao, Runxiu Zheng, Silin Xie, Jian Yi, Feiying Wang, Xia Li, Lan Song, Wen Zhang, Jianmin Fan, Li Qin, Aiguo Dai
Format: Artículo Open Access
Veröffentlicht: Wiley 2025
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1867015010915450880
author Junlan Tan
Xianya Cao
Runxiu Zheng
Silin Xie
Jian Yi
Feiying Wang
Xia Li
Lan Song
Wen Zhang
Jianmin Fan
Li Qin
Aiguo Dai
author_facet Junlan Tan
Xianya Cao
Runxiu Zheng
Silin Xie
Jian Yi
Feiying Wang
Xia Li
Lan Song
Wen Zhang
Jianmin Fan
Li Qin
Aiguo Dai
Junlan Tan
Xianya Cao
Runxiu Zheng
Silin Xie
Jian Yi
Feiying Wang
Xia Li
Lan Song
Wen Zhang
Jianmin Fan
Li Qin
Aiguo Dai
collection Wiley Open Access
contents Celastrol Ameliorates Hypoxia‐Induced Pulmonary Hypertension by Regulation of the PDE5‐cGMP‐PKG Signaling Pathway Junlan Tan Xianya Cao Runxiu Zheng Silin Xie Jian Yi Feiying Wang Xia Li Lan Song Wen Zhang Jianmin Fan Li Qin Aiguo Dai Phytotherapy Research ABSTRACTPulmonary hypertension (PH) is a severe pulmonary vascular disease characterized by poor clinical outcomes and limited therapeutic options. Celastrol (CEL), a natural product derived from Tripterygium wilfordii Hook F, has shown therapeutic potential in PH models, although its mechanisms are not fully understood. This study aims to investigate the role of CEL in PH and explore its potential underlying mechanisms. This study investigates the role of CEL in PH and explores its underlying mechanisms. We evaluated the effects of CEL in a chronic hypoxia‐induced PH rat model and hypoxia‐stimulated human pulmonary arterial smooth muscle cells (HPASMCs). Bioinformatics and network pharmacology were employed to identify potential targets and pathways, which were then validated through mechanistic and functional analyses. CEL significantly reduced right ventricular systolic pressure, hypertrophy, fibrosis, and dysfunction in hypoxia‐induced PH rats. It also decreased proliferating cell nuclear antigen expression and promoted apoptosis in pulmonary arterioles. Our findings suggest that CEL's therapeutic effects are mediated through the modulation of phosphodiesterase 5 (PDE5) and the activation of the cGMP‐PKG signaling pathway. In HPASMCs, CEL treatment mirrored the in vivo results, and PDE5 overexpression negated CEL's antiproliferative, antimigratory, and pro‐apoptotic effects. CEL ameliorates pulmonary vascular remodeling and right ventricular dysfunction in PH, potentially through the PDE5‐cGMP‐PKG signaling pathway. These findings position CEL as a promising candidate for PH therapy. 10.1002/ptr.8446 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1002/ptr.8446
format Artículo Open Access
id wiley_oa_10_1002_ptr_8446
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2025
publisher Wiley
record_format wiley_oa
spellingShingle Celastrol Ameliorates Hypoxia‐Induced Pulmonary Hypertension by Regulation of the PDE5‐cGMP‐PKG Signaling Pathway
Junlan Tan
Xianya Cao
Runxiu Zheng
Silin Xie
Jian Yi
Feiying Wang
Xia Li
Lan Song
Wen Zhang
Jianmin Fan
Li Qin
Aiguo Dai
Phytotherapy Research
Celastrol Ameliorates Hypoxia‐Induced Pulmonary Hypertension by Regulation of the PDE5‐cGMP‐PKG Signaling Pathway Junlan Tan Xianya Cao Runxiu Zheng Silin Xie Jian Yi Feiying Wang Xia Li Lan Song Wen Zhang Jianmin Fan Li Qin Aiguo Dai Phytotherapy Research ABSTRACTPulmonary hypertension (PH) is a severe pulmonary vascular disease characterized by poor clinical outcomes and limited therapeutic options. Celastrol (CEL), a natural product derived from Tripterygium wilfordii Hook F, has shown therapeutic potential in PH models, although its mechanisms are not fully understood. This study aims to investigate the role of CEL in PH and explore its potential underlying mechanisms. This study investigates the role of CEL in PH and explores its underlying mechanisms. We evaluated the effects of CEL in a chronic hypoxia‐induced PH rat model and hypoxia‐stimulated human pulmonary arterial smooth muscle cells (HPASMCs). Bioinformatics and network pharmacology were employed to identify potential targets and pathways, which were then validated through mechanistic and functional analyses. CEL significantly reduced right ventricular systolic pressure, hypertrophy, fibrosis, and dysfunction in hypoxia‐induced PH rats. It also decreased proliferating cell nuclear antigen expression and promoted apoptosis in pulmonary arterioles. Our findings suggest that CEL's therapeutic effects are mediated through the modulation of phosphodiesterase 5 (PDE5) and the activation of the cGMP‐PKG signaling pathway. In HPASMCs, CEL treatment mirrored the in vivo results, and PDE5 overexpression negated CEL's antiproliferative, antimigratory, and pro‐apoptotic effects. CEL ameliorates pulmonary vascular remodeling and right ventricular dysfunction in PH, potentially through the PDE5‐cGMP‐PKG signaling pathway. These findings position CEL as a promising candidate for PH therapy. 10.1002/ptr.8446 http://onlinelibrary.wiley.com/termsAndConditions#vor
title Celastrol Ameliorates Hypoxia‐Induced Pulmonary Hypertension by Regulation of the PDE5‐cGMP‐PKG Signaling Pathway
topic Phytotherapy Research
url https://onlinelibrary.wiley.com/doi/10.1002/ptr.8446